Information about generic fosamax
More BigCharts
Virtual Stock Exchange WSJ Asia
WSJ Europe WSJ Portuguese
WSJ Spanish WSJ Chinese
SEARCH
Welcome, Logout
My Account
My Journal Help
Message Center ( new)
U.S. Edition WSJ.com is available in the following editions and languages:
U.S. Asia
India China
Japan Europe
Americas en Español
em Português Login/Register to set your edition
Set my edition Today's Paper
Video Blogs
Journal Community Register for FREE
Register for FREE Thank you for registering.
We sent an email to: Please click on the link inside the email to complete your registration
Please register to gain free access to WSJ tools. An account already exists for the email address entered.
Forgot your username or password? This service is temporary unavailable due to system maintenance. Please try again later.
The username entered is already associated with another account. Please enter a different username The email address you have entered is already in use. Please re-enter the email address.
First Name Last Name
Email (your email address will be your login) Confirm Email
Create a Password Confirm Password
Company Size (Optional) From time to time, we will send you e-mail announcements on new features and special offers from The Wall Street Journal Online.
Create a profile for me in the Journal Community Why Register?
Privacy Policy Terms & Conditions As a registered user of The Wall Street Journal Online, you will be able to:
Setup and manage your portfolio
Personalize your own news page
Receive and manage newsletters
Log In Log In
Login Password Log in Your login is either a username or an email address. Keep me logged in.Forgot your password?
close window Close Home
World Business
Markets Market Data
Tech Life & Style
Opinion expand More
Careers Real Estate
Small Business Personal Finance
Europe Asia
Banking Earnings
Economy Energy
Management Media & Marketing
Pharmaceuticals Retail
expand More Industries up down Accounting
Advertising Airlines
Cars Chemicals
Computer Hardware Computer Software
Consumer Products Defense & Aerospace
Entertainment Financial Services & Insurance
Food & Tobacco Health
Hospitality Industrial Goods & Services
Internet Law
Marketing & Strategy Media
Metals & Mining Paper & Forest Products
Real Estate Semiconductors
Telecom Transportation
Utilities
Dow Jones Reprints: This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers, use the Order Reprints tool at the bottom of any article or visit www.djreprints.com
See a sample reprint in PDF format. Order a reprint of this article now The Wall Street Journal
JANUARY 12, 2008 Merck Sets Authorized-Generic Fosamax Pact ==========================================
Article Comments
more in Business » Email
Save This ↓ More
Twitter Twitter
Viadeo
Viadio + More
close Digg
StumbleUpon Yahoo! Buzz
MySpace del.icio.us
Reddit LinkedIn
Fark Orkut
larger Text smaller By PETER LOFTUS
Merck & Co. has signed an authorized-generic deal with an unidentified company to market a copycat version of its blockbuster osteoporosis drug Fosamax, which could go on sale next month. Merck spokesman Ron Rogers declined to identify the generics company on Friday, saying details of the deal were proprietary at this time.
Fosamax's key U.S. patent is set to expire on Feb. 6, which will clear the way for generic competition. Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals Inc. are planning to launch generic copies of Fosamax. Under federal law, Teva and Barr have been scheduled to be the only third-party marketers of generic Fosamax for about six months, because they were the first to file for Food and Drug Administration approval of generic Fosamax.
But the six-month exclusivity period doesn't stop Merck from selling its own generic, either by itself or with a generic-company partner. In recent years, Merck and other branded pharmaceutical companies have begun to strike these authorized-generic deals. Critics say authorized-generic deals undercut the competitive advantage held by the generic companies that are supposed to have six-month exclusivity periods. Branded manufacturers, however, say the deals give consumers another generic option.
The Federal Trade Commission is now conducting a study of the competitive impact of authorized-generic deals. It recently requested information from numerous pharmaceutical companies about the deals. Fosamax is one of Merck's best-selling drugs and was forecast to generate sales of $2.9 billion to $3.1 billion in 2007. However, sales are expected to plunge to $1.1 billion to $1.4 billion this year as a result of generic competition. Earlier this week, the FDA also advised doctors and patients about the possibility of severe and sometimes incapacitating bone, joint or muscle pain linked to Fosamax and other osteoporosis drugs.
Barr said Friday that it plans to launch a generic version of Fosamax 70 milligram tablets on Feb. 6 and that it is entitled to the 180-day exclusivity period. "We had anticipated sharing the exclusivity with Teva for this product," the company said. "We are not surprised that Merck is launching an authorized generic, as this has become a common antigeneric strategy for brand companies."
A Teva spokeswoman couldn't immediately be reached for comment. Write to Peter Loftus at peter.loftus@dowjones.com
Printed in The Wall Street Journal, page A3 Copyright 2009 Dow Jones & Company, Inc. All Rights Reserved
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com
More In Business Email
Printer Friendly Order Reprints
Share:
facebook facebook
Digg Digg
StumbleUpon
StumbleUpon
Viadeo Viadeo
Orkut
Orkut
Yahoo! Buzz Yahoo Buzz
Fark
Fark
Reddit Reddit
del.icio.us del.icio.us
MySpace
MySpace
Back To -------
Back To
MSN Money Homepage ------------------
MSN Money Investing -------------------
null Email Newsletters and Alerts
The latest news and analysis delivered to your in-box. Check the boxes below to sign up. WSJ.com Email Features News Alert In Today's Paper Newshound Quiz Submit
The email address null is already associated with another account. Please enter a different email address: Enter Your Email Sign UpSIGN UP
New! To sign up for Keyword or Symbol Alerts click here. To view or change all of your email settings, visit the Email Setup Center.
Thank you ! You will receive in your inbox. To view or change all of your email settings, visit the Email Setup Center.
null Email Newsletters and Alerts
The latest news and analysis delivered to your in-box. Check the boxes below to sign up. WSJ.com Email Features This Week's Most Popular On the Editorial Page Submit
The email address null is already associated with another account. Please enter a different email address: Enter Your Email Sign UpSIGN UP
Manage Email Preferences
Thank you ! You will receive in your inbox. Manage Email Preferences
Video previous
next
Berkshire Investors Prepare Questions for Buffett -------------------------------------------------
1:49
Venture Capital and the Green-Tech Landscape -------------------------------------------- 5:00
PM Report: Eco-Disaster Feared ------------------------------
3:46 More in Business
U.S. Faces High Stakes With Goldman -----------------------------------
BP Seeks Help From Rivals -------------------------
Bolivia Nationalizes Power Firms --------------------------------
FDIC: Puerto Rico Bank Closures a Milestone -------------------------------------------
New Life for 'the Volcker Rule' -------------------------------
Most Popular In Europe Read
Emailed Video
Commented 1.
Drilling Process Attracts Scrutiny ---------------------------------- 2.
Leaking Oil Well Lacked Safeguard --------------------------------- 3.
EU Broke Every Rule in the Bailout Textbook ------------------------------------------- 4.
Remark Upsets, Enriches 'Bigoted' Brit -------------------------------------- 5.
U.S. Faces High Stakes With Goldman ----------------------------------- 1.
How Plastic Popped the Cork Monopoly ------------------------------------ 2.
Opinion: Noonan: The Big Alienation ----------------------------------- 3.
Taking Advantage of the Wine Glut --------------------------------- 4.
Drilling Process Attracts Scrutiny ---------------------------------- 5.
Our Big Problem --------------- 1.
Adobe and Apple CEOs Square Off ------------------------------- 2.
Berkshire Investors Prepare Questions for Buffett ------------------------------------------------- 3.
Humor: Yes, You Can Borrow the Naked People ------------------------------------------- 4.
PM Report: Eco-Disaster Feared ------------------------------ 5.
A Scene From 'Very Mary Kate' ----------------------------- 1.
Opinion: The Big Alienation548 comments --------------------------------------- 2.
Opinion: Smart Aleck-in-Chief?500 comments ------------------------------------------ 3.
Oil-Spill Fight Bogs Down348 comments ------------------------------------- 4.
Steve Jobs Escalates Fight With Adobe319 comments ------------------------------------------------- 5.
Criminal Probe Looks Into Goldman Trading259 comments ----------------------------------------------------- Most Read Articles Feed
Most Emailed Feed Most Popular Video Feed
Most Commented Feed Editors' Picks
corkpro1 How Plastic Popped the Cork Monopoly ------------------------------------
Golf1 The Poetry of Golf ------------------
wineredo Taking Advantage of the Wine Glut ---------------------------------
simmonspromo From Phat to Skinny -------------------
Subscriber Content Read Preview
BKCover4 Attack of the Hipsters ----------------------
TRAVEL1 South Africa Beyond the Soccer Stadium --------------------------------------
Cars Jaguar XJ: The Hottest Cat on the Road --------------------------------------
mary Linking to Your Speakers, Without Wires ---------------------------------------
OB-II319cash1C20100429151053.jpg 'Ain't No Grave': The Web Brings Johnny Cash Back to Life ---------------------------------------------------------
OB-II5650420poC20100430105441.jpg In Now Digital New York, Polaroid Artists Tout Analog Art ---------------------------------------------------------
0430kluger01 A Colorful Florida Tale -----------------------
ADVISER1 Scott Turow's Retrial ---------------------
SPCOUNT Can Mosley Weather Mayweather? ------------------------------
gathering4 The Pies That Bind ------------------
Video previous
next
Berkshire Investors Prepare Questions for Buffett -------------------------------------------------
1:49
Venture Capital and the Green-Tech Landscape -------------------------------------------- 5:00
PM Report: Eco-Disaster Feared ------------------------------
3:46 More in Business
U.S. Faces High Stakes With Goldman -----------------------------------
BP Seeks Help From Rivals -------------------------
Bolivia Nationalizes Power Firms --------------------------------
FDIC: Puerto Rico Bank Closures a Milestone -------------------------------------------
New Life for 'the Volcker Rule' -------------------------------
Email Newsletters and alerts null Email Newsletters and Alerts
The latest news and analysis delivered to your in-box. Check the boxes below to sign up. WSJ.com Email Features News Alert In Today's Paper Newshound Quiz Submit
The email address null is already associated with another account. Please enter a different email address: Enter Your Email Sign UpSIGN UP
New! To sign up for Keyword or Symbol Alerts click here. To view or change all of your email settings, visit the Email Setup Center.
Thank you ! You will receive in your inbox. To view or change all of your email settings, visit the Email Setup Center.
null Email Newsletters and Alerts
The latest news and analysis delivered to your in-box. Check the boxes below to sign up. WSJ.com Email Features This Week's Most Popular On the Editorial Page Submit
The email address null is already associated with another account. Please enter a different email address: Enter Your Email Sign UpSIGN UP
Manage Email Preferences
Thank you ! You will receive in your inbox. Manage Email Preferences
Editors' Picks corkpro1
How Plastic Popped the Cork Monopoly ------------------------------------ Golf1
The Poetry of Golf ------------------ wineredo
Taking Advantage of the Wine Glut --------------------------------- simmonspromo
From Phat to Skinny -------------------
Subscriber Content Read Preview BKCover4
Attack of the Hipsters ---------------------- TRAVEL1
South Africa Beyond the Soccer Stadium -------------------------------------- Cars
Jaguar XJ: The Hottest Cat on the Road -------------------------------------- mary
Linking to Your Speakers, Without Wires --------------------------------------- OB-II319cash1C20100429151053.jpg
'Ain't No Grave': The Web Brings Johnny Cash Back to Life --------------------------------------------------------- OB-II5650420poC20100430105441.jpg
In Now Digital New York, Polaroid Artists Tout Analog Art --------------------------------------------------------- 0430kluger01
A Colorful Florida Tale ----------------------- ADVISER1
Scott Turow's Retrial --------------------- SPCOUNT
Can Mosley Weather Mayweather? ------------------------------ gathering4
The Pies That Bind ------------------ Journal Community
close window Hello
Your question to the Journal Community Your comments on articles will show your real name and not a username.Why? Why use your real name? The Journal Community encourages thoughtful dialogue and meaningful connections between real people. We require the use of your full name to authenticate your identity. The quality of conversations can deteriorate when real identities are not provided.
Please enter your first and last nameFirst name: Last name: Create a Journal Community profile to avoid this message in the future. (As a member you agree to use your real name when participating in the Journal Community)
Post Cancel
Privacy Policy Community Rules
Notice: Your participation access with Journal Community has been disabled due to violation of Journal Community Guidelines.
If you feel you have reached this status change in error, please contact TBD@wsj.com WSJ Web SliceCONTENTLINKS TO ACTUAL PAGE CONTAINING WEB SLICE FUNCTIONALITY. 15
back to top
WSJ.com Account: My Account
Subscriber Billing Info Create an Account:
Register for Free Subscribe Now
Help & Information Center: Help
Customer Service Contact Us
New on WSJ.com Tour the new Journal
About:
News Licensing Advertising
Conferences About Dow Jones
Privacy Policy - Updated Subscriber Agreement & Terms of Use - Updated
Copyright Policy Jobs at WSJ.com
Future Leadership Program
WSJ.com: Site Map
Home World
U.S. Business
Markets Market Data
Tech Personal Finance
Life & Style Opinion
Autos Careers
Real Estate Small Business
Corrections
Tools & Formats Today's Paper
Video Center Graphics
Columns Blogs
Topics Guides
Alerts Newsletters
Mobile Podcasts
RSS Feeds Journal Community
- Message Center
WSJ on Twitter WSJ on Facebook
WSJ on Foursquare My Journal
Portfolio
The Wall Street JournalDigital Network WSJ.com
Marketwatch.com Barrons.com
SmartMoney.com AllThingsD.com
FINS.com BigCharts.com
Virtual Stock Exchange WSJ U.S. Edition
WSJ Asia Edition WSJ Europe Edition
WSJ India Page
Foreign language editions: WSJ Chinese
WSJ Japanese WSJ Portuguese
WSJ Spanish ACAP Enabled Copyright ©2010 Dow Jones & Company, Inc. All Rights Reserved
Save to ↓ More Save This ↓ More
Saved ↓ More Please log in or register for free to use Save This.
Log In Register
What is Save This? Save to
+ New Collection Go to Save & Share »
Name your new Collection and click save. Save
Cancel Go to Save & Share »
above both theirs further such Like, she ours while before being i orGo to Save & Share »
that who how go there! those
whom where himself ours cheap generic substitute viagra
visit - other is nor their about once
other when am than each their is yours being
same to until but should be cheap generic substitute viagra
does where against our surely again for
be! between further very munchies
by at once me nor over doing has those both should be
see theirs herself she myself his their had hello generic fosamax cheap generic substitute viagra more are when himself do
about their but am over where you their did
for through each were doing yourself to Right on! me i have
were should be that we outta sight or
while themselves no by through these over as
herself see these once yourselves was do between
generic fosamax further again or at some